No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
WST240719P290000
- 0.25
- -1.46-85.38%
15min DelayClose Jul 12 16:00 ET
0.25High0.25Low
0.25Open1.71Pre Close1 Volume32 Open Interest290.00Strike Price25.00Turnover84.59%IV10.29%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.25Extrinsic Value100Contract SizeAmericanOptions Type-0.1393Delta0.0065Gamma127.91Leverage Ratio-0.6577Theta-0.0070Rho-17.81Eff Leverage0.0891Vega
Intraday
- 5D
- Daily
News
West to Host Second-Quarter 2024 Conference Call
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
What to Expect From West Pharmaceutical Services' Q2 2024 Earnings Report
Express News | West Pharmaceutical Services: New Term Loan Which Was Fully Drawn at Closing and Matures on July 2, 2027
Express News | West Pharmaceutical Services: Third Amendment Established Incremental Term Loan in Stated Principal Amount of $130.0 Mln
Express News | West Pharmaceutical Services: Third Amendment to Credit Agreement Which Amends Credit Agreement, Dated as of March 28, 2019
Does West Pharmaceutical Services (NYSE:WST) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' It's only natural to co
Comments
RECAP
U.S. equity indexes rose after Thursday, with the $Nasdaq Composite Index(.IXIC.US$ lagging the pack, as investors weighed retail sales and jobless claims ahead of more inflation data this week.
The $S&P 500 Index(.SPX.US$ rose 0.58% to 5,029, a new closing high with the $Dow Jones Industrial Average(.DJI.US$ up 0.91% to 38,664. The $Nasdaq Composite Index(.IXIC.US$ was moderately higher at 15,906, af...
U.S. equity indexes rose after Thursday, with the $Nasdaq Composite Index(.IXIC.US$ lagging the pack, as investors weighed retail sales and jobless claims ahead of more inflation data this week.
The $S&P 500 Index(.SPX.US$ rose 0.58% to 5,029, a new closing high with the $Dow Jones Industrial Average(.DJI.US$ up 0.91% to 38,664. The $Nasdaq Composite Index(.IXIC.US$ was moderately higher at 15,906, af...
41
5
Analysts worry about the company's shifting tone and the enduring effect of clients' inventory management on West's finances. Doubts also arise about the company's demand visibility and if current trends suggest a fundamental issue in West's base business.
Jefferies analyst David Windley sees FDA approvals of GLP-1s for obesity treatment as a huge opportunity for the manufacturing supply chain. He also notes high rivalry in the injectable fill/finish market. Windley upgraded West Pharmaceutical to Buy, raising its price target by 66% to $536, citing its global footprint and capacity to meet growing GLP-1s demand.
The market sentiment around West Pharmaceutical Services hasn't changed much over the past five years, with the share price seemingly reacting to the EPS. The recent improvement in TSR could indicate that the business is getting better with time.
1
Read more